Position in NAMS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$153,996
+$9,951 QoQ
Shares Held
4,544
+1.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#161
of 197 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Quarry LP holds $23,882,426 across 180 Biotechnology names. NAMS ranks #33 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
40,175 | $7,523,974 | |
| 2 | ACAD |
Acadia Pharmaceuticals Inc
|
50,155 | $1,268,921 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
17,624 | $1,008,445 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
2,754 | $922,011 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
25,000 | $834,750 | |
| 6 | DTIL |
Precision Biosciences Inc
|
97,915 | $769,611 | |
| 7 | AGIO |
Agios Pharmaceuticals, Inc.
|
20,147 | $747,655 | |
| 8 | INSM |
INSMED Inc
|
6,254 | $666,801 |
All Filings in NAMS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $153,996 | 4,544 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $144,045 | 4,500 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $105,240 | 3,000 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $195,525 | 6,875 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $126,770 | 7,000 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $24,564 | 1,200 | Shares | Other | 2025-05-15 | |
| 2024-09-30 | $107,900 | 6,500 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $4,860 | 253 | Shares | Other | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||